'Unique Oncology Platform': Gilead (GILD) Earns Two Upgrades After Beat-and-raise Quarter

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. ACN
4. IBM
5. DPZ
6. PRIM
7. META
8. IMNN
9. NAVN
10. NVDA

Go back to 'Unique Oncology Platform': Gilead (GILD) Earns Two Upgrades After Beat-and-raise Quarter
Gilead Sciences (NASDAQ: GILD) Delayed: 124.87 --0 (-0%)
Previous Close $124.87    52 Week High $108.63 
Open $124.87    52 Week Low $71.39 
Day High $124.87    P/E 68.99 
Day Low $124.87    EPS $1.81 
Volume 9,591